DP

Dimpleben Panjwani

Director Director DIN 02979912
DIN 02979912 First appointment Mar 2010 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2010
Shareholding value Locked Premium profile

About Dimpleben Panjwani

Dimpleben Panjwani has 16 years in corporate governance. Formerly with 1 company, such as Admit Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 02979912
Primary Designation Director
First Appointment 30 Mar 2010
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Director 30 Mar 2010 2005 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Admit Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Dimpleben Panjwani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dimpleben Panjwani

Dimpleben Panjwani has 16 years in corporate governance. Formerly with 1 company, such as Admit Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Dimpleben Panjwani is associated with 0 companies as a director.

Dimpleben Panjwani has expertise in General Business.

Dimpleben Panjwani has 16 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available